Risk factors for hospitalization for cancer patients with SARS-CoV-2 infection

Autor:	Saad Z. Usmani, Emily Baldrige, Ashley Sumrall, Seungjean Chai, Brittany K. Ragon, Peter M. Voorhees, Sally Jeanne Trufan, Courtney Schepel, Jimmy J. Hwang, Edward S. Kim, Michael R. Grunwald, Derek Raghavan, Edward A. Copelan, Zainab Shahid, Nilanjan Ghosh, Antoinette R. Tan, Laura W. Musselwhite
Rok vydání:	2021
Předmět:	Cancer Research medicine.medical_specialty 2019-20 coronavirus outbreak Oncology Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Internal medicine Severe disease Medicine Cancer business medicine.disease
Zdroj:	Journal of Clinical Oncology. 39:e18753-e18753
ISSN:	1527-7755 0732-183X
Popis:	e18753 Background: Cancer patients are more susceptible to developing severe disease associated with SARS-CoV-2 infection. Herein, data from a high-volume cancer center is presented highlighting risk factors associated with hospitalization with COVID-19 disease. Methods: Cancer patients in the Levine Cancer Institute COVID19 database who were tested for SARS-CoV-2 due to clinical illness from March 1, 2020 to October 29, 2020 with 90 days follow-up are described here. Patients’ demographic and clinical information were retrospectively entered into a REDCap database from chart reviews. Differences in distributions were identified between hospitalized and non-hospitalized patients using the chi-squared test with uni- and multivariable logistic regression models. Statistical significance was set at p
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::71819cb1a21cdb9ea8f8c29e59858303 https://doi.org/10.1200/jco.2021.39.15_suppl.e18753 Zobrazit plný text záznamu